Last edited by Shashakar
Sunday, August 2, 2020 | History

3 edition of The Ambivalence of cytostatic therapy found in the catalog.

The Ambivalence of cytostatic therapy

  • 26 Want to read
  • 18 Currently reading

Published by Springer-Verlag in Berlin, New York .
Written in English

    Subjects:
  • Cancer -- Chemotherapy -- Congresses.,
  • Antineoplastic agents -- Congresses.,
  • Antineoplastic agents -- Adverse effects.,
  • Cell division -- Drug effects.,
  • Neoplasms -- Drug therapy.

  • Edition Notes

    Statementedited by E. Grundmann and R. Gross.
    SeriesRecent results in cancer research ;, 52
    ContributionsGrundmann, E., Gross, Rudolf, 1917-, Gesellschaft zur Bekämpfung der Krebskrankheiten Nordrhein-Westfalen., European Organization for Research on Treatment of Cancer., Schweizerische Nationalliga für Krebsbekämpfung und Krebsforschung.
    Classifications
    LC ClassificationsRC261 .R35 vol. 52, RC271.C5 .R35 vol. 52
    The Physical Object
    Paginationviii, 244 p. :
    Number of Pages244
    ID Numbers
    Open LibraryOL5187304M
    ISBN 100387072403
    LC Control Number75006742

    This study considered implications of intergenerational ambivalence for each party's psychological well-being and physical health. Participants included families (N = ) with a son or daughter aged 22 to 49, their mother and -Partner-Interaction Models (APIM) revealed that parents and offspring who self-reported greater ambivalence showed poorer psychological well-being.   How can therapy clients get unstuck and work steadily toward desired goals? This book presents an integrative model of ambivalence in psychotherapy and presents effective, practical ways to recognize and deal with it. Emphasis is given to two techniques with significant empirical support: motivational interviewing and the two-chair approach.

    Chemotherapy is an effective adjunctive therapy for patients with anaplastic oligodendrogliomas (i.e., deletions of chromosomes 1p and 19q), primary CNS lymphomas, and certain pediatric tumors (e.g., high-risk medulloblastoma). Ekkehard Grundmann is the author of Kursus Der Allgemeinen Histopathologie ( avg rating, 1 rating, 0 reviews, published ), Recent Results in Canc 1/5(1).

    MOTIVATIONAL INTERVIEWING: Preparing People to Change Addictive Behavior, and the most recently revised third edition, are books written by William R. Miller & Stephen Rollnick. These publications contain a wealth of information for professionals working with people who are working on change, including a host of contributions from a variety of colleagues offering unique perspectives and. book. These theories are relatively recent modi-fications of the humanistic approach to psycho-therapy and counseling. In a Septem , e-mail communication with me, Miller stated, “MI belongs with the ‘third force’ humanistic group of approaches. Some people mistakenly identify it as a cognitive-behavior therapy.”.


Share this book
You might also like
New York State Board of Regents recommendations for legislative action on state aid to schools, 1987.

New York State Board of Regents recommendations for legislative action on state aid to schools, 1987.

social problem

social problem

Outlook for energy.

Outlook for energy.

Pulling punches

Pulling punches

Name and place index to Illustrated historical atlas of the counties of Leeds and Grenville, Ontario

Name and place index to Illustrated historical atlas of the counties of Leeds and Grenville, Ontario

The biology of sexually transmitted diseases

The biology of sexually transmitted diseases

Hearings, 88th Congress, 1963-1964.

Hearings, 88th Congress, 1963-1964.

law of torts

law of torts

Taxation of fringe benefits under the latest rules

Taxation of fringe benefits under the latest rules

McCalls Book of Rugmaking

McCalls Book of Rugmaking

Advanced Analytical Chemistry (Ellis Horwood Series in Analytical Chemistry)

Advanced Analytical Chemistry (Ellis Horwood Series in Analytical Chemistry)

The New Holiday guide to France.

The New Holiday guide to France.

The revenge game

The revenge game

The Ambivalence of cytostatic therapy Download PDF EPUB FB2

The Ambivalence of Cytostatic Therapy. Editors (view affiliations) Ekkehard Grundmann; Rudolf W. Gross; Book. Citations; Search within book. Front Matter. Pages I-VIII. PDF. The Effect of Cytostatic Therapy on Cellular Immunity in vitro. Winnewisser, H. Theml, H. Begemann.

The Effect of Cytostatic Therapy on Cellular Immunity in vitro.- The Balance of Host Immunocompetence in Chemical Carcinogenesis and "Nonspecific" Immunotherapy.- Tumor Induction in Immunologically Privileged Sites.- Patterns of Neoplastic and Nonneoplastic Diseases of Praomys (Mastomys) Natalensis.- Summary.- III.

Cell Synchronization in Tumor. The Ambivalence of Cytostatic Therapy. [Ekkehard Grundmann; Rudolf W J Gross] -- E. GRUNDMANN The question as to whether cytostatic drugs might be carcinogenic has been presented and discussed in three experimental studies. (ebook) Ambivalence of Cytostatic Therapy () from Dymocks online store.

Gesellschaft zur Bekampfung der Krebskrankheiten. We are open, in-store and online. Some orders may experience a slight delay due to COVID restrictions. Cytostatic treatment is always better, as it increases the waiting time to cancer progression, compared to no treatment (Eqs 3 and 5, Fig 2).

The improvement is due to the therapy both reducing the establishment probability of events and reducing (or keeping constant) the number of births at the carrying capacity when compared to no : Jani V. Anttila, Mikhail Shubin, Johannes Cairns, Florian Borse, Qingli Guo, Tommi Mononen, Ignacio.

Handling cytostatic drugs requires a number of organizational and technical systems in order to guarantee the best possible protection for personnel.

This booklet focuses on various ways of protecting personnel from potential hazards through the careful handling of cytostatic drugs, and for this reason, product protection. ambivalence 4. The counseling style is generally quiet and elicits information from the client 5.

The counselor is directive, in that they help the client to examine and resolve ambivalence 6. Readiness to change is not a trait of the client, but a fluctuating result of interpersonal interaction 7. The therapeutic relationship resembles a. Most molecular components of the different cytostatic groups can only affect those phases of the cell cycle that involve cell division.

This mechanism particularly refers to the so-called cell-cycle-specific cytotoxic drugs. There are a few cytostatic agents that can affect a cell in any phase of the cell cycle.

The role of cytotoxic drugs in cancer therapy has decreased slightly with the development of drug therapy. However, they continue to be widely used.

Several types of cytotoxic drugs are used in cancer therapy that together have different kinds of effect. The most usual method is to administer a combination of several different cytotoxic drugs.

Separate chapters discuss organ toxicity, chromosomal damage and carcinogenicity in experimental animals. Epidemiological studies of second cancers following cytostatic therapy are the subject of the fourth section of the volume which concludes with a group of papers on new strategies for reducing the carcinogenicity of cytostatic drugs.

In: Grundmann E., Gross R.W.J. (eds) The Ambivalence of Cytostatic Therapy. Recent Results in Cancer Research (Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer), vol Springer, Berlin, Heidelberg.

Cytostasis (cyto – cell; stasis – stoppage) is the inhibition of cell growth and multiplication. Cytostatic refers to a cellular component or medicine that inhibits cell growth.

Cytostasis is an important prerequisite for structured multicellular organisms. Without regulation of cell growth and division only unorganized heaps of cells would be possible. Author(s): Gross,R(Rudolf); Grundmann,E(Ekkehard) Title(s): The Ambivalence of cytostatic therapy/ edited by E.

Grundmann and R. Gross. Country of Publication. The immune system plays an important role in the host's defenses against cancer. Immunodeficiency states are associated with an increased incidence of neoplasia. In primary immunodeficiency states, t. Continuous Therapy. Cytostatic agents, such as many of the newer targeted agents, require continuous exposure to maintain disease control.

Drugs that have a potent, although short-lived, effect on a tumor will not work well with intermittent dosing because when the drug is removed, the tumor will move from a static to an active phase.

The records of 1, patients with Hodgkin's disease seen at the Mayo Clinic from to were reviewed in search of any later‐developing myelo‐proliferative disorders. No cases of polycythemia. Penn, Malignant Disease in Immunodeficient States in Man, The Ambivalence of Cytostatic Therapy, /_12, (), ().

Gross has 15 books on Goodreads with 4 ratings. Gross’s most popular book is Leukamie. Recent Results in Cancer Research, Volume The Ambivalence of Cytostatic Therapy by.

Ekkehard Grundmann (Editor), R. Gross (Editor) Cytostatic Theory - a Double Edged Sword by. Ekkehard Grundmann, R. Gross. Ambivalence refers to the state of experiencing conflicting beliefs or feelings simultaneously.

The prefix ambi means both; the suffix valence derives from. behavior change by helping clients to explore and resolve ambivalence. Compared with nondirective counseling, it is more focused and goal directed.

This method works on facilitating and engaging intrinsic motivation within the client in order to change behavior. The examination and resolution of ambivalence is a central purpose, and the. Abstract Hydroxyurea is a cytotoxic drug which has been found to be of only limited usefulness in the chemotherapy of solid tumors.

However, recent clinical work suggests hydroxyurea might be quite. Therapy Center. NEW. published a book titled "The Monster Within—The Hidden Side of Motherhood" which deals with the subject of maternal ambivalence. The book is an attempt to.Current practice in childhood CIDP immunotherapy as described in case reports and series is as follows: (1) First-line therapy: either IVIg g/kg/day for 5 days repeated every 3 to 4 weeks, or corticosteroids (oral prednisone) 1 to 2 mg/kg/day for 4 to 6 weeks and then slow tapering.

(2) Second-line therapy: azathioprine 1 to 3 mg/kg/day.